Saturday, 15 August 2020

Alternate Text

ACTIVE PHARMACEUTICAL INGREDIENTS

COMMERCIAL PRODUCTS TERAPEUTIC CATEGORY STATUS
Clidinium Bromide Anti-cholinergic Commercial
Atropine Sulphate Anti-cholinergic Commercial
Homatropine Methylbromide Anti-cholinergic Commercial
Homatropine Hydrobromide Anti-cholinergic Commercial
Buprenorphine Base Pain Management/De addiction Commercial
Buprenorphine HCl Pain Management/De addiction Commercial
Naloxone HCl Pain Management/De addiction Commercial
Oxybutynin Chloride/ Hydrochloride Anti-cholinergic Commercial
Glycopyrrolate/Glycopyronium Bromide Anti-cholinergic Commercial
Glycopyrrolate/Glycopyronium Bromide - Micronised (D90 < 6 micron, D99 < 10 micron) Anti-cholinergic Inhalation Commercial
Isopropamide Iodide Anti-cholinergic Commercial
Pramoxine HCl Topical Anaesthetic Commercial
Naltrexone HCl Pain Management/De addiction Under Development
Etizolam Anxiolytic Under Development
Baclofen Muscle Spasticity Under Development
Prazepam Anxiolytic Under Development
Loprazolam Anxiolytic Under Development
Ipratropium Bromide COPD,Asthma Under Development
Clotiazepam Anxiolytic Under Development